News
Study suggests best time for battling symptoms is during perimenopause

A study has shown that lifestyle interventions during menopause are more valuable when applied during peri-menopause – so how can femtech help?
Women going through menopause may experience symptoms such as weight gain, adverse changes in body composition, hot flashes and an increased risk of chronic disease such as osteoporosis.
While a lot of healthcare focus remains on lessening the symptoms of menopause, a lot of these changes begin during perimenopause. Studies have shown that menopause can cause weight gain as well as a redistribution of fat towards the abdomen. Perimenopause has been highlighted as a key transition point for these changes.
In this study, researchers evaluated women at all stages of menopause including premenopause, perimenopause and postmenopause to understand changes in resting and exercise metabolism in conjunction with body composition. They aimed to identify the relationship between body composition and lifestyle factors such as dietary habits, physical activity and sleep.
The results showed that perimenopause may be the best window for lifestyle intervention because this group experienced elevated percentages of fat, lower lean body mass and a shift towards central obesity. The greatest changes were observed between the premenopause and perimenopause periods indicating that the transition stimulates the changes that are later experienced in menopause.
The researchers noted that menopausal women should engage in activities that help to maintain lean mass, such as resistance exercise as well as maintain or increase oxidative capacity.
How can femtech help with menopause?
Menopause is a key area of research and development for femtech developers. It’s also a huge market of opportunity as the global menopause market was valued at USD$14.7 billion in 2020 with an expected rise to 5.7 per cent to reach $22.7 billion in 2028.
Menopause is viewed more as a journey within femtech with many apps or platforms focusing on each stage of the transition. It also offers a more holistic approach to symptom management that can be personalised to each woman’s experience through data collection. The more data you input, the better your recommendations on lifestyle changes become. This personalised tailored approach can be lost through interaction with GPs who often don’t have time to consider all approaches other than hormone treatments. Tech can often be complimentary alongside doctor recommendations to increase the options on offer.
Studies such as this show that early intervention when it comes to symptoms may help to slow the severity by the time women get to menopause. But, with a distinct lack of education around perimenopause or menopause itself, this may be the biggest task for femtech companies to tackle.
It is estimated that by 2025, there will be over 1 billion women experiencing menopause in the world. This is estimated to be 12 per cent of the entire world population of 8 billion.
As both Generation X and Y approach menopausal ages, it creates another opportunity for tech. This is the first real wave of tech-savvy patients who have grown accustomed to the digitalisation of health. They think nothing of using apps, platforms or telemedicine because it’s always been there as an option only to be accelerated during the pandemic.
All the signs point to easy adoption for those experiencing early menopause signs such as weight gain or sleep issues. However, it is going to be an uphill battle to get the education out there to women about the prospect of menopause symptom management in an environment where most do not know perimenopause happens.
While it’s not clear how femtech will bridge the gap between education, awareness and getting more users on platforms – it is clear there is a desperate need for solutions.
Read more: NatWest data shows women overtaking men for the first time in start-up numbers
Fertility
Toxins and climate harms having ‘alarming’ effect on fertility, research warns

Simultaneous exposure to toxic chemicals and climate-related heat may be worsening fertility harms across humans and wildlife, research suggests.
The review of scientific literature looks at how endocrine-disrupting chemicals, often found in plastic, together with climate-related effects such as heat stress, are each linked to lower fertility and fecundity, meaning the ability to reproduce, across species including humans, wildlife and invertebrates.
Though the reproductive harms of each issue in isolation are well studied, there is little research on what happens when living organisms are exposed to both.
“Together, the two issues are likely to pose a greater threat to fertility, and the additive effect is “alarming”, said Susanne Brander, a study lead author and courtesy faculty at Oregon State University.
“You’re not just getting exposed to one, but two, stressors at the same time that both may affect your fertility, and in turn the overall impact is going to be a bit worse,” Brander said.
The paper looked at 177 studies.
Shanna Swan, a co-author on the new paper, co-produced a 2017 study that found sperm levels among men in western countries had fallen by more than 50 per cent over four decades. Other research has suggested human fertility has been declining at a similar rate.
The University of Washington’s Institute for Health Metrics and Evaluation has previously said the world was approaching a “low-fertility future”, with more than three quarters of countries below replacement rate by 2050.
The new paper’s authors focused on the effects of endocrine-disrupting chemicals and substances, including microplastics, bisphenol, phthalates and PFAS.
These are thought to cause a range of serious reproductive problems, disrupt hormones and be a potential driver of falling fertility.
Brander said the harms linked to these chemicals are often similar across organisms, from invertebrates to humans.
Phthalates, for example, have been linked to altered sperm shape in invertebrates, spermatogenesis in rodents, meaning sperm production, and reduced sperm counts in humans.
PFAS are also thought to affect sperm quality, and both have been linked to hormone disruption.
The chemicals are widespread in consumer goods, so people are often regularly exposed.
Meanwhile, previous research has shown how rising temperatures, lower oxygen levels and heat stress, among other effects linked to climate change, may also worsen infertility.
Heat stress has been found to affect human hormones, and is linked to spermatogenesis in rodents and bulls.
Research shows temperature also plays a role in sex determination in fish, reptiles and amphibians.
The species has evolved to choose which sex it produces in part based on temperature, and the heating planet can “push it too far in one direction or the other, which overrides that evolutionary benefit”, Brander said.
Similarly, many endocrine disruptors may alter environmental sex determination.
The study set out some of the overlapping effects of chemical exposure and climate change across taxonomic groups, from invertebrates to humans.
In birds, for example, exposure to increased temperature, PFAS, organochlorines and pyrethroids may each individually cause abnormal sperm, increased fledgling mortality, abnormal testes and population decline.
“What happens if they’re exposed to more than one of those stressors at the same time? There has been little exploration of that question.
“Even if there have not been a lot of studies looking at these simultaneously, if you have two different factors that both cause the same adverse effect, then there’s a likelihood that they are going to be additive,” Brander said.
Katie Pelch, a senior scientist with the Natural Resources Defense Council nonprofit, who was not part of the study, said the authors had reviewed high-quality science.
She said she wanted to see more examples of the overlap in impacts, but agreed with the overall premise.
“It is likely [multiple stressors] would have an additive effect, at very least, even if they have different mechanisms of harm,” Pelch added.
The solution to the systemic problems would involve tackling climate change and reducing the use of toxic chemicals.
The study cites the global reduction in the use of DDT and PCBs achieved under the Stockholm Convention as an example of an effective measure, but Brander said much more is needed.
“There is enough evidence in both areas to act to reduce our impact on the planet,” she said.
Pregnancy
Home blood pressure checks could lower heart risks for new mothers – study
Fertility
Researcher explores weight loss jab impact on PCOS
Entrepreneur4 weeks agoThree sessions that show exactly where women’s health is heading in 2026
Fertility4 days agoFuture Fertility raises Series A financing to scale AI tools redefining fertility care worldwide
Pregnancy4 weeks agoHow NIPT has evolved and what AI NIPT means in 2026
News4 weeks agoTwo weeks left to make your mark in women’s cardiovascular health
Opinion4 weeks agoQ1 momentum: Female founders are advancing, but the system still hasn’t caught up
Fertility2 weeks agoFuture Fertility partners with Japan’s leading IVF provider, Kato Ladies Clinic
Mental health6 days agoLifting weights shows mental health and cognitive benefits in older women, study finds
Menopause2 weeks agoMore research needed to understand link between brain fog and menopause, expert says
















1 Comment